These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12831811)

  • 21. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
    Yamada K; Mawulawde K; Menard MT; Shimizu A; Aretz HT; Choo JK; Allison KS; Slisz JK; Sachs DH; Madsen JC
    J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):709-19. PubMed ID: 10733759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in the diagnosis and management of cardiac allograft vasculopathy.
    Mehra MR; Ventura HO; Smart FW; Stapleton DD; Collins TJ; Ramee SR; Murgo JP; White CJ
    Tex Heart Inst J; 1995; 22(2):138-44. PubMed ID: 7647597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac allograft vasculopathy: the green lane hospital experience 1987-1998.
    Dixon SR; Ruygrok PN; Agnew TM; Lund M; Aldersley PF; Gibbs HC; Whitlock RM; Haydock DA; Coverdale HA
    N Z Med J; 1999 Nov; 112(1099):417-20. PubMed ID: 10678223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac allograft vasculopathy: pathology, prevention and treatment.
    Kass M; Haddad H
    Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current understanding and management of allograft vasculopathy.
    Lietz K; Miller LW
    Semin Thorac Cardiovasc Surg; 2004; 16(4):386-94. PubMed ID: 15635545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial activation and development of coronary artery disease in transplanted human hearts.
    Labarrere CA; Nelson DR; Faulk WP
    JAMA; 1997 Oct; 278(14):1169-75. PubMed ID: 9326477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.
    Erinc K; Yamani MH; Starling RC; Crowe T; Hobbs R; Bott-Silverman C; Rincon G; Young JB; Feng J; Cook DJ; Smedira N; Tuzcu EM
    J Heart Lung Transplant; 2005 Aug; 24(8):1033-8. PubMed ID: 16102438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma".
    Valantine HA
    Transplantation; 2003 Sep; 76(6):891-9. PubMed ID: 14508350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings].
    Kerber S; Rahmel A; Karbenn U; Heinemann-Vechtel O; Fechtrup C; Lamp B; Block M; Budde T; Hoffmeier A; Weyand M
    Z Kardiol; 1994 Mar; 83(3):215-24. PubMed ID: 8178545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac allograft vasculopathy: current concepts and treatment.
    Waller J; Brook NR; Nicholson ML
    Transpl Int; 2003 Jun; 16(6):367-75. PubMed ID: 12756523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac allograft vasculopathy: recent developments.
    Schmauss D; Weis M
    Circulation; 2008 Apr; 117(16):2131-41. PubMed ID: 18427143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor-specific antibodies are associated with micro- and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart-transplanted patients.
    Clemmensen TS; Koefoed-Nielsen P; Jensen LA; Poulsen SH; Holm NR; Løgstrup BB; Christiansen EH; Dijkstra J; Valen KPB; Eiskjaer H
    Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28627046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors?
    Wehner JR; Baldwin WM
    Curr Opin Organ Transplant; 2010 Oct; 15(5):639-44. PubMed ID: 20689436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.
    Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(5):724-9. PubMed ID: 8241209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography.
    Derumeaux G; Redonnet M; Soyer R; Cribier A; Letac B
    J Heart Lung Transplant; 1998 Mar; 17(3):259-67. PubMed ID: 9563602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of allograft vasculopathy in heart transplantation.
    Segovia J; Gómez-Bueno M; Alonso-Pulpón L
    Expert Opin Pharmacother; 2006 Dec; 7(17):2369-83. PubMed ID: 17109612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.